AP2006003734A0 - Inhalation formulation - Google Patents

Inhalation formulation

Info

Publication number
AP2006003734A0
AP2006003734A0 AP2006003734A AP2006003734A AP2006003734A0 AP 2006003734 A0 AP2006003734 A0 AP 2006003734A0 AP 2006003734 A AP2006003734 A AP 2006003734A AP 2006003734 A AP2006003734 A AP 2006003734A AP 2006003734 A0 AP2006003734 A0 AP 2006003734A0
Authority
AP
ARIPO
Prior art keywords
inhalation formulation
inhalation
formulation
Prior art date
Application number
AP2006003734A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AP2006003734A0 publication Critical patent/AP2006003734A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AP2006003734A 2004-03-12 2005-03-14 Inhalation formulation AP2006003734A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN312MU2004 2004-03-12
PCT/GB2005/001119 WO2005087192A2 (fr) 2004-03-12 2005-03-14 Formulations pour inhalation

Publications (1)

Publication Number Publication Date
AP2006003734A0 true AP2006003734A0 (en) 2006-10-31

Family

ID=34962995

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003734A AP2006003734A0 (en) 2004-03-12 2005-03-14 Inhalation formulation

Country Status (9)

Country Link
EP (1) EP1732526A2 (fr)
JP (1) JP2007528889A (fr)
KR (1) KR20060135873A (fr)
AP (1) AP2006003734A0 (fr)
IL (1) IL177596A0 (fr)
MA (1) MA28462B1 (fr)
RU (1) RU2006136025A (fr)
WO (1) WO2005087192A2 (fr)
ZA (1) ZA200606801B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016052897A1 (fr) * 2014-09-30 2016-04-07 Hanmi Pharm. Co., Ltd. Poudre sèche pour formulation d'inhalation ayant une stabilité améliorée de principes actifs combinés

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
GB2235627B (en) * 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
TR199701169T1 (xx) * 1995-04-14 1998-03-21 Glaxo Wellcome Inc. Salmeterol i�in �l��lm�� doz inhaleri.
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
WO2004019985A1 (fr) * 2002-08-29 2004-03-11 Cipla Ltd Produits et compositions pharmaceutiques comprenant des agents anticholinergiques specifiques, des agonistes beta-2 et des corticosteroides

Also Published As

Publication number Publication date
MA28462B1 (fr) 2007-03-01
RU2006136025A (ru) 2008-04-20
JP2007528889A (ja) 2007-10-18
ZA200606801B (en) 2008-05-28
WO2005087192A3 (fr) 2006-06-15
IL177596A0 (en) 2006-12-10
EP1732526A2 (fr) 2006-12-20
WO2005087192A2 (fr) 2005-09-22
KR20060135873A (ko) 2006-12-29

Similar Documents

Publication Publication Date Title
PL1970842T3 (pl) Inhalator ręczny
GB0407990D0 (en) Inhaler
GB0423565D0 (en) Formulation
GB0412530D0 (en) Formulation
GB0406288D0 (en) Respirators
GB0505538D0 (en) Inhalation devices
IL180487A0 (en) Medicament
GB0402491D0 (en) Medicaments
GB0423511D0 (en) Inhaler
AU303092S (en) Inhalation device
GB0419597D0 (en) Resuscitators
GB0421731D0 (en) Respiratory monitor
GB0403733D0 (en) Medicaments
AP2006003734A0 (en) Inhalation formulation
PL1688129T3 (pl) Nowy preparat terapeutyczny
GB0506035D0 (en) Improved formulation
IL179208A0 (en) Intereferon formulations
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
HU0400157V0 (en) Inhalator
GB0401114D0 (en) Formulation
GB0407958D0 (en) Formulation
GB0426142D0 (en) Formulation
GB0412412D0 (en) New formulation
GB0409129D0 (en) New formulation